PTK2 and cancer: We show that FAK deletion in cancer cells derived from mouse KPC tumours reprogrammes the cellular response to IFNγ, increasing both antigen diversity through activation of the immunoproteasome and surface presentation through upregulation of MHC-I to promote immunosurveillance.